Deep search
Web
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past hour
Any time
Past 24 hours
Past 7 days
Past 30 days
Most recent
Best match
59m
FDA approves Spravato, nasal spray derived from Ketamine
The FDA approves Spravato, a nasal spray derived from Ketamine, to help some people treat depression. Dr. Bill Hartman from UW Health shares more.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Hughes Fire prompts evacs
Senate advances nomination
Confirmed as CIA director
Judge halts executive order
Orders release of secret docs
Slander conviction upheld
Corpse flower draws crowd
CNN announcing layoffs
Sentenced to over 50 years
'Bling Empire' star dies
New panel to probe Jan. 6
NYC aesthetician charged
KKK flyers in Kentucky
Houston refinery closure
Curran to lead Secret Service
San Antonio officers shot
Mulls SC governor’s bid
Former NC judge dies
Thai same-sex marriage law
Defends diversity policies
Announces return to skiing
Exits Quebec operations
DOJ halts civil rights work
ACLU sues over deportations
Recalling over 270K vehicles
Picked as ambassador to EU
ICC targets Taliban leaders
Keys upsets Swiatek
Jobless claims rise slightly
Heat suspend Butler again
Mortgage rates drop
Related topics
Johnson & Johnson
depression
Food and Drug Administration
Feedback